25 XP   0   0   10

Affymax Inc.
Buy, Hold or Sell?

Let's analyse Affymax together

PenkeI guess you are interested in Affymax Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Affymax Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Affymax Inc.

I send you an email if I find something interesting about Affymax Inc..

Quick analysis of Affymax (30 sec.)










What can you expect buying and holding a share of Affymax? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.14
Expected worth in 1 year
$0.27
How sure are you?
22.2%

+ What do you gain per year?

Total Gains per Share
$0.13
Return On Investment
16,154.4%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0007 - $0.0008
How sure are you?
50%

1. Valuation of Affymax (5 min.)




Live pricePrice per Share (EOD)

$0.00

Intrinsic Value Per Share

$25.15 - $30.84

Total Value Per Share

$25.29 - $30.98

2. Growth of Affymax (5 min.)




Is Affymax growing?

Current yearPrevious yearGrowGrow %
How rich?$5.1m$14.7m-$14.6m-10,884.4%

How much money is Affymax making?

Current yearPrevious yearGrowGrow %
Making money$673.5k-$26m$26.7m3,968.3%
Net Profit Margin-123,118.6%-218.7%--

How much money comes from the company's main activities?

3. Financial Health of Affymax (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Affymax? (5 min.)

Welcome investor! Affymax's management wants to use your money to grow the business. In return you get a share of Affymax.

What can you expect buying and holding a share of Affymax?

First you should know what it really means to hold a share of Affymax. And how you can make/lose money.

Speculation

The Price per Share of Affymax is $0.0008. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Affymax.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Affymax, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.14. Based on the TTM, the Book Value Change Per Share is $0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.56 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Affymax.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.1924,036.3%0.022,245.6%-0.69-86,867.1%-0.28-35,036.4%-0.33-41,452.1%
Usd Book Value Change Per Share0.2025,026.6%0.034,038.6%-0.56-69,821.8%-0.01-1,232.5%0.00478.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.2025,026.6%0.034,038.6%-0.56-69,821.8%-0.01-1,232.5%0.00478.8%
Usd Price Per Share0.10-0.76-10.61-9.23-11.71-
Price to Earnings Ratio0.13--4.47--2.62--5.45--9.22-
Price-to-Total Gains Ratio0.51--31.88--13.47--28.85--40.57-
Price to Book Ratio0.74--22.81-53.36--7.49-1.65-
Price-to-Total Gains Ratio0.51--31.88--13.47--28.85--40.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0008
Number of shares1250000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.03-0.01
Usd Total Gains Per Share0.03-0.01
Gains per Quarter (1250000 shares)40,386.02-12,324.92
Gains per Year (1250000 shares)161,544.06-49,299.68
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101615441615340-49300-49310
203230883230780-98599-98610
304846324846220-147899-147910
406461766461660-197199-197210
508077208077100-246498-246510
609692649692540-295798-295810
70113080811307980-345098-345110
80129235312923420-394397-394410
90145389714538860-443697-443710
100161544116154300-492997-493010

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%4.032.00.011.1%4.032.00.011.1%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%8.028.00.022.2%8.028.00.022.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.036.00.0%0.00.036.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%8.028.00.022.2%8.028.00.022.2%

Fundamentals of Affymax

About Affymax Inc.

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

Fundamental data was last updated by Penke on 2024-05-14 00:14:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Affymax Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Affymax earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • A Net Profit Margin of 17,164.3% means that $171.64 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Affymax Inc.:

  • The MRQ is 17,164.3%. The company is making a huge profit. +2
  • The TTM is -123,118.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ17,164.3%TTM-123,118.6%+140,282.9%
TTM-123,118.6%YOY-218.7%-122,899.9%
TTM-123,118.6%5Y-24,791.0%-98,327.6%
5Y-24,791.0%10Y-22,441.3%-2,349.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ17,164.3%-171.8%+17,336.1%
TTM-123,118.6%-211.9%-122,906.7%
YOY-218.7%-263.3%+44.6%
5Y-24,791.0%-414.0%-24,377.0%
10Y-22,441.3%-552.3%-21,889.0%
1.1.2. Return on Assets

Shows how efficient Affymax is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • 133.9% Return on Assets means that Affymax generated $1.34 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Affymax Inc.:

  • The MRQ is 133.9%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 20.6%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ133.9%TTM20.6%+113.3%
TTM20.6%YOY-10.7%+31.3%
TTM20.6%5Y-2.1%+22.6%
5Y-2.1%10Y-5.6%+3.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ133.9%-11.9%+145.8%
TTM20.6%-11.5%+32.1%
YOY-10.7%-10.9%+0.2%
5Y-2.1%-13.1%+11.0%
10Y-5.6%-14.4%+8.8%
1.1.3. Return on Equity

Shows how efficient Affymax is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • 139.4% Return on Equity means Affymax generated $1.39 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Affymax Inc.:

  • The MRQ is 139.4%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 34.9%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ139.4%TTM34.9%+104.6%
TTM34.9%YOY966.9%-932.0%
TTM34.9%5Y194.2%-159.3%
5Y194.2%10Y87.9%+106.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ139.4%-15.3%+154.7%
TTM34.9%-14.6%+49.5%
YOY966.9%-13.6%+980.5%
5Y194.2%-17.7%+211.9%
10Y87.9%-19.2%+107.1%

1.2. Operating Efficiency of Affymax Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Affymax is operating .

  • Measures how much profit Affymax makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • An Operating Margin of -2,269.0% means the company generated $-22.69  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Affymax Inc.:

  • The MRQ is -2,269.0%. The company is operating very inefficient. -2
  • The TTM is -127,976.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2,269.0%TTM-127,976.9%+125,707.9%
TTM-127,976.9%YOY-647.2%-127,329.7%
TTM-127,976.9%5Y-25,847.6%-102,129.3%
5Y-25,847.6%10Y-18,761.6%-7,085.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,269.0%-336.0%-1,933.0%
TTM-127,976.9%-224.0%-127,752.9%
YOY-647.2%-280.1%-367.1%
5Y-25,847.6%-412.2%-25,435.4%
10Y-18,761.6%-521.7%-18,239.9%
1.2.2. Operating Ratio

Measures how efficient Affymax is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 50.76 means that the operating costs are $50.76 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Affymax Inc.:

  • The MRQ is 50.762. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1,057.996. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ50.762TTM1,057.996-1,007.234
TTM1,057.996YOY19.455+1,038.541
TTM1,057.9965Y219.121+838.876
5Y219.12110Y361.066-141.946
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ50.7623.005+47.757
TTM1,057.9963.247+1,054.749
YOY19.4553.619+15.836
5Y219.1215.262+213.859
10Y361.0666.874+354.192

1.3. Liquidity of Affymax Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Affymax is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 20.81 means the company has $20.81 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Affymax Inc.:

  • The MRQ is 20.813. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.739. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ20.813TTM5.739+15.074
TTM5.739YOY1.755+3.985
TTM5.7395Y3.724+2.015
5Y3.72410Y6.340-2.616
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.8133.805+17.008
TTM5.7394.158+1.581
YOY1.7555.252-3.497
5Y3.7246.087-2.363
10Y6.3406.434-0.094
1.3.2. Quick Ratio

Measures if Affymax is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • A Quick Ratio of 15.88 means the company can pay off $15.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Affymax Inc.:

  • The MRQ is 15.883. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.453. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ15.883TTM4.453+11.430
TTM4.453YOY1.764+2.689
TTM4.4535Y4.128+0.325
5Y4.12810Y9.026-4.897
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.8833.202+12.681
TTM4.4533.816+0.637
YOY1.7645.183-3.419
5Y4.1285.929-1.801
10Y9.0266.351+2.675

1.4. Solvency of Affymax Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Affymax assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Affymax to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.04 means that Affymax assets are financed with 4.0% credit (debt) and the remaining percentage (100% - 4.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Affymax Inc.:

  • The MRQ is 0.040. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.912. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.040TTM0.912-0.872
TTM0.912YOY0.911+0.001
TTM0.9125Y0.652+0.260
5Y0.65210Y0.943-0.291
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0400.344-0.304
TTM0.9120.342+0.570
YOY0.9110.279+0.632
5Y0.6520.366+0.286
10Y0.9430.380+0.563
1.4.2. Debt to Equity Ratio

Measures if Affymax is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • A Debt to Equity ratio of 4.1% means that company has $0.04 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Affymax Inc.:

  • The MRQ is 0.041. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.010. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.041TTM0.010+0.031
TTM0.010YOY19.415-19.405
TTM0.0105Y4.391-4.381
5Y4.39110Y3.869+0.522
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0410.398-0.357
TTM0.0100.415-0.405
YOY19.4150.353+19.062
5Y4.3910.446+3.945
10Y3.8690.470+3.399

2. Market Valuation of Affymax Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Affymax generates.

  • Above 15 is considered overpriced but always compare Affymax to the Biotechnology industry mean.
  • A PE ratio of 0.13 means the investor is paying $0.13 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Affymax Inc.:

  • The EOD is 0.001. Based on the earnings, the company is cheap. +2
  • The MRQ is 0.132. Based on the earnings, the company is cheap. +2
  • The TTM is -4.474. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.001MRQ0.132-0.131
MRQ0.132TTM-4.474+4.606
TTM-4.474YOY-2.618-1.856
TTM-4.4745Y-5.451+0.977
5Y-5.45110Y-9.220+3.769
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.001-2.313+2.314
MRQ0.132-2.535+2.667
TTM-4.474-2.723-1.751
YOY-2.618-3.958+1.340
5Y-5.451-6.316+0.865
10Y-9.220-6.544-2.676
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Affymax Inc.:

  • The EOD is -0.005. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.653. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.796. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.005MRQ-0.653+0.648
MRQ-0.653TTM-4.796+4.143
TTM-4.796YOY-4.108-0.688
TTM-4.7965Y-3.993-0.803
5Y-3.99310Y-8.588+4.595
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.005-3.099+3.094
MRQ-0.653-3.270+2.617
TTM-4.796-3.523-1.273
YOY-4.108-5.220+1.112
5Y-3.993-8.080+4.087
10Y-8.588-8.637+0.049
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Affymax is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.74 means the investor is paying $0.74 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Affymax Inc.:

  • The EOD is 0.006. Based on the equity, the company is cheap. +2
  • The MRQ is 0.736. Based on the equity, the company is cheap. +2
  • The TTM is -22.813. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.006MRQ0.736-0.730
MRQ0.736TTM-22.813+23.549
TTM-22.813YOY53.358-76.171
TTM-22.8135Y-7.495-15.319
5Y-7.49510Y1.649-9.144
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0062.009-2.003
MRQ0.7362.029-1.293
TTM-22.8132.065-24.878
YOY53.3582.688+50.670
5Y-7.4953.688-11.183
10Y1.6494.095-2.446
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Affymax Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2000.032+520%-0.559+379%-0.010+105%0.004+5127%
Book Value Per Share--0.1380.004+3751%0.393-65%1.366-90%0.866-84%
Current Ratio--20.8135.739+263%1.755+1086%3.724+459%6.340+228%
Debt To Asset Ratio--0.0400.912-96%0.911-96%0.652-94%0.943-96%
Debt To Equity Ratio--0.0410.010+300%19.415-100%4.391-99%3.869-99%
Dividend Per Share----0%-0%-0%-0%
Eps--0.1920.018+970%-0.695+461%-0.280+246%-0.332+272%
Free Cash Flow Per Share---0.039-0.056+44%-0.733+1785%-0.372+858%-0.286+635%
Free Cash Flow To Equity Per Share---0.039-0.058+48%-0.724+1762%-0.162+317%-0.043+10%
Gross Profit Margin--1.0001.279-22%1.0000%1.056-5%1.031-3%
Intrinsic Value_10Y_max--30.840--------
Intrinsic Value_10Y_min--25.155--------
Intrinsic Value_1Y_max---0.586--------
Intrinsic Value_1Y_min---0.578--------
Intrinsic Value_3Y_max--1.041--------
Intrinsic Value_3Y_min--0.937--------
Intrinsic Value_5Y_max--6.046--------
Intrinsic Value_5Y_min--5.371--------
Market Cap29992.080-12588%3805245.15028506534.788-87%397911810.625-99%346008569.533-99%439047221.990-99%
Net Profit Margin--171.643-1231.186+817%-2.187+101%-247.910+244%-224.413+231%
Operating Margin---22.690-1279.769+5540%-6.472-71%-258.476+1039%-187.616+727%
Operating Ratio--50.7621057.996-95%19.455+161%219.121-77%361.066-86%
Pb Ratio0.006-12588%0.736-22.813+3200%53.358-99%-7.495+1118%1.649-55%
Pe Ratio0.001-12588%0.132-4.474+3491%-2.618+2084%-5.451+4231%-9.220+7087%
Price Per Share0.001-12588%0.1020.760-87%10.614-99%9.229-99%11.711-99%
Price To Free Cash Flow Ratio-0.005+99%-0.653-4.796+635%-4.108+529%-3.993+512%-8.588+1215%
Price To Total Gains Ratio0.004-12588%0.507-31.885+6389%-13.475+2758%-28.849+5791%-40.566+8102%
Quick Ratio--15.8834.453+257%1.764+800%4.128+285%9.026+76%
Return On Assets--1.3390.206+551%-0.107+108%-0.021+102%-0.056+104%
Return On Equity--1.3940.349+300%9.669-86%1.942-28%0.879+59%
Total Gains Per Share--0.2000.032+520%-0.559+379%-0.010+105%0.004+5127%
Usd Book Value--5170000.000134250.000+3751%14746500.000-65%51198700.000-90%32456027.778-84%
Usd Book Value Change Per Share--0.2000.032+520%-0.559+379%-0.010+105%0.004+5127%
Usd Book Value Per Share--0.1380.004+3751%0.393-65%1.366-90%0.866-84%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.1920.018+970%-0.695+461%-0.280+246%-0.332+272%
Usd Free Cash Flow---1457000.000-2091500.000+44%-27466750.000+1785%-13957200.000+858%-10117888.889+594%
Usd Free Cash Flow Per Share---0.039-0.056+44%-0.733+1785%-0.372+858%-0.286+635%
Usd Free Cash Flow To Equity Per Share---0.039-0.058+48%-0.724+1762%-0.162+317%-0.043+10%
Usd Market Cap29992.080-12588%3805245.15028506534.788-87%397911810.625-99%346008569.533-99%439047221.990-99%
Usd Price Per Share0.001-12588%0.1020.760-87%10.614-99%9.229-99%11.711-99%
Usd Profit--7209000.000673500.000+970%-26052750.000+461%-10508050.000+246%-12432305.556+272%
Usd Revenue--42000.00010583.000+297%7443750.000-99%15907266.600-100%14163314.778-100%
Usd Total Gains Per Share--0.2000.032+520%-0.559+379%-0.010+105%0.004+5127%
 EOD+3 -5MRQTTM+26 -8YOY+21 -125Y+22 -1210Y+24 -10

3.2. Fundamental Score

Let's check the fundamental score of Affymax Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.001
Price to Book Ratio (EOD)Between0-10.006
Net Profit Margin (MRQ)Greater than0171.643
Operating Margin (MRQ)Greater than0-22.690
Quick Ratio (MRQ)Greater than115.883
Current Ratio (MRQ)Greater than120.813
Debt to Asset Ratio (MRQ)Less than10.040
Debt to Equity Ratio (MRQ)Less than10.041
Return on Equity (MRQ)Greater than0.151.394
Return on Assets (MRQ)Greater than0.051.339
Total9/10 (90.0%)

3.3. Technical Score

Let's check the technical score of Affymax Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.209
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2013-06-302013-09-302013-12-312014-03-312014-06-30
Net Working Capital  -1,896165-1,731-818-2,549-794-3,3437,5834,240



Latest Balance Sheet

Balance Sheet of 2014-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets5,384
Total Liabilities214
Total Stockholder Equity5,170
 As reported
Total Liabilities 214
Total Stockholder Equity+ 5,170
Total Assets = 5,384

Assets

Total Assets5,384
Total Current Assets4,454
Long-term Assets930
Total Current Assets
Cash And Cash Equivalents 3,399
Other Current Assets 1
Total Current Assets  (as reported)4,454
Total Current Assets  (calculated)3,400
+/- 1,054
Long-term Assets
Long-term Assets Other 930
Long-term Assets  (as reported)930
Long-term Assets  (calculated)930
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities214
Long-term Liabilities0
Total Stockholder Equity5,170
Total Current Liabilities
Accounts payable 80
Other Current Liabilities 134
Total Current Liabilities  (as reported)214
Total Current Liabilities  (calculated)214
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock37
Retained Earnings -552,320
Other Stockholders Equity 557,453
Total Stockholder Equity (as reported)5,170
Total Stockholder Equity (calculated)5,170
+/-0
Other
Cash and Short Term Investments 3,399
Common Stock Shares Outstanding 37,490
Liabilities and Stockholders Equity 5,384
Net Debt -3,399
Net Tangible Assets 5,170
Net Working Capital 4,240



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-31
> Total Assets 
0
0
0
27,728
0
0
0
60,960
79,498
177,465
150,562
249,988
246,675
238,279
229,054
225,792
214,541
205,869
188,896
167,720
192,419
167,679
144,932
211,510
189,985
189,136
157,475
131,387
165,885
141,394
134,249
118,995
169,871
143,967
132,749
118,217
66,718
20,913
15,545
7,443
6,463
5,384
5,3846,4637,44315,54520,91366,718118,217132,749143,967169,871118,995134,249141,394165,885131,387157,475189,136189,985211,510144,932167,679192,419167,720188,896205,869214,541225,792229,054238,279246,675249,988150,562177,46579,49860,96000027,728000
   > Total Current Assets 
0
0
0
25,340
0
0
0
58,615
77,124
174,678
147,681
240,624
237,679
231,912
221,593
194,812
172,253
167,354
154,105
127,081
157,583
133,998
127,405
190,739
160,680
162,137
115,749
99,542
144,188
119,993
122,890
107,620
154,750
129,029
118,221
102,510
56,797
11,452
7,443
6,322
5,456
4,454
4,4545,4566,3227,44311,45256,797102,510118,221129,029154,750107,620122,890119,993144,18899,542115,749162,137160,680190,739127,405133,998157,583127,081154,105167,354172,253194,812221,593231,912237,679240,624147,681174,67877,12458,61500025,340000
       Cash And Cash Equivalents 
0
0
0
1,657
0
0
0
14,399
15,256
9,339
41,070
147,541
83,459
78,324
51,966
108,215
86,302
70,243
38,257
24,046
79,685
75,585
67,336
125,296
68,188
64,178
50,245
63,499
96,142
73,591
66,025
54,339
59,777
88,734
89,169
68,265
46,615
10,503
6,852
5,597
4,856
3,399
3,3994,8565,5976,85210,50346,61568,26589,16988,73459,77754,33966,02573,59196,14263,49950,24564,17868,188125,29667,33675,58579,68524,04638,25770,24386,302108,21551,96678,32483,459147,54141,0709,33915,25614,3990001,657000
       Short-term Investments 
0
0
0
23,063
0
0
0
43,494
60,729
58,420
101,058
76,751
143,236
139,555
152,144
60,122
62,011
70,740
72,447
70,673
46,775
29,951
32,354
35,292
68,949
77,651
55,129
33,582
45,856
39,717
49,222
44,165
32,619
29,342
9,684
9,717
7,221
0
0
0
0
0
000007,2219,7179,68429,34232,61944,16549,22239,71745,85633,58255,12977,65168,94935,29232,35429,95146,77570,67372,44770,74062,01160,122152,144139,555143,23676,751101,05858,42060,72943,49400023,063000
       Net Receivables 
0
0
0
0
0
0
0
0
0
105,071
206
10,191
5,235
9,955
8,703
15,331
15,393
17,701
32,878
24,353
22,488
20,476
17,470
20,004
13,680
10,400
4,349
0
0
4,234
5,452
6,937
59,019
3,230
9,710
18,365
881
0
0
0
0
0
0000088118,3659,7103,23059,0196,9375,4524,234004,34910,40013,68020,00417,47020,47622,48824,35332,87817,70115,39315,3318,7039,9555,23510,191206105,071000000000
       Other Current Assets 
0
0
0
620
0
0
0
722
0
0
4,296
5,090
4,698
3,027
7,729
11,133
8,536
8,659
2,541
7,998
8,624
7,986
10,245
10,136
9,863
9,908
6,026
2,450
2,190
2,451
2,191
2,179
3,335
5,683
7,618
3,069
60
949
1
1
1
1
1111949603,0697,6185,6833,3352,1792,1912,4512,1902,4506,0269,9089,86310,13610,2457,9868,6247,9982,5418,6598,53611,1337,7293,0274,6985,0904,29600722000620000
   > Long-term Assets 
0
0
0
2,388
0
0
0
2,345
2,374
2,787
2,881
9,364
8,996
6,367
7,461
30,980
42,288
38,515
34,791
40,639
34,836
33,681
17,527
20,771
29,305
26,999
41,726
31,845
21,697
21,401
11,359
11,375
15,121
14,938
14,528
15,707
9,921
9,461
8,102
1,121
1,007
930
9301,0071,1218,1029,4619,92115,70714,52814,93815,12111,37511,35921,40121,69731,84541,72626,99929,30520,77117,52733,68134,83640,63934,79138,51542,28830,9807,4616,3678,9969,3642,8812,7872,3742,3450002,388000
       Property Plant Equipment 
0
0
0
1,053
0
0
0
1,110
1,139
1,552
1,646
2,014
2,539
3,425
4,032
4,470
4,634
6,090
6,616
6,952
6,628
6,442
5,963
5,469
5,127
4,682
4,250
3,982
3,782
3,253
3,071
3,012
2,999
3,186
3,024
2,981
647
0
0
0
0
0
000006472,9813,0243,1862,9993,0123,0713,2533,7823,9824,2504,6825,1275,4695,9636,4426,6286,9526,6166,0904,6344,4704,0323,4252,5392,0141,6461,5521,1391,1100001,053000
       Other Assets 
0
0
0
1,335
0
0
0
1,235
0
0
1,235
7,350
6,457
2,942
3,429
26,510
37,654
32,425
28,175
33,687
28,208
27,239
11,564
15,302
24,178
22,317
37,476
27,863
17,915
18,148
8,288
8,362
12,122
11,752
11,504
12,726
9,274
9,461
8,102
1,121
1,007
0
01,0071,1218,1029,4619,27412,72611,50411,75212,1228,3628,28818,14817,91527,86337,47622,31724,17815,30211,56427,23928,20833,68728,17532,42537,65426,5103,4292,9426,4577,3501,235001,2350001,335000
> Total Liabilities 
0
0
0
114,890
0
0
0
174,651
201,139
302,938
281,035
133,089
135,074
134,170
134,475
141,607
143,735
150,532
156,757
158,736
160,738
155,116
147,664
144,605
127,783
104,996
82,150
58,840
45,841
30,830
31,316
42,998
57,434
59,878
67,593
109,936
81,494
20,588
16,414
8,871
8,799
214
2148,7998,87116,41420,58881,494109,93667,59359,87857,43442,99831,31630,83045,84158,84082,150104,996127,783144,605147,664155,116160,738158,736156,757150,532143,735141,607134,475134,170135,074133,089281,035302,938201,139174,651000114,890000
   > Total Current Liabilities 
0
0
0
2,146
0
0
0
5,377
4,659
24,424
6,893
11,972
11,527
13,832
15,912
55,698
61,393
72,222
83,759
93,351
105,580
112,742
120,268
133,721
116,905
94,117
71,277
47,617
34,600
19,401
17,189
19,766
21,808
24,967
27,340
99,075
70,854
13,348
9,174
8,871
8,799
214
2148,7998,8719,17413,34870,85499,07527,34024,96721,80819,76617,18919,40134,60047,61771,27794,117116,905133,721120,268112,742105,58093,35183,75972,22261,39355,69815,91213,83211,52711,9726,89324,4244,6595,3770002,146000
       Short-term Debt 
0
0
0
0
0
0
0
223
280
286
289
293
277
236
188
133
81
52
27
7
0
0
0
9,192
9,041
5,378
0
0
0
0
0
0
901
1,823
2,766
8,844
8,020
0
0
0
0
0
000008,0208,8442,7661,8239010000005,3789,0419,19200072752811331882362772932892862802230000000
       Accounts payable 
0
0
0
806
0
0
0
3,336
3,050
22,011
5,241
9,113
8,746
9,724
12,118
9,348
3,205
3,191
3,618
614
1,855
5,141
2,464
464
3,159
2,467
1,541
321
1,042
851
2,579
941
528
3,050
3,766
6,591
9,307
1,471
157
101
236
80
802361011571,4719,3076,5913,7663,0505289412,5798511,0423211,5412,4673,1594642,4645,1411,8556143,6183,1913,2059,34812,1189,7248,7469,1135,24122,0113,0503,336000806000
       Other Current Liabilities 
0
0
0
1,340
0
0
0
1,818
1,329
2,127
1,363
2,566
2,504
3,872
3,606
6,729
33,678
47,306
60,544
37,800
44,340
44,193
50,358
104,186
94,204
84,436
38,549
28,799
26,558
18,550
14,610
18,825
20,379
20,094
20,808
83,640
53,527
11,877
9,017
8,770
8,563
134
1348,5638,7709,01711,87753,52783,64020,80820,09420,37918,82514,61018,55026,55828,79938,54984,43694,204104,18650,35844,19344,34037,80060,54447,30633,6786,7293,6063,8722,5042,5661,3632,1271,3291,8180001,340000
   > Long-term Liabilities 
0
0
0
112,744
0
0
0
169,274
196,480
278,514
274,142
121,117
123,547
120,338
118,563
85,909
82,342
78,310
72,998
65,385
55,158
42,374
27,396
10,884
10,878
10,879
10,873
11,223
11,241
11,429
14,127
23,232
35,626
34,911
40,253
10,861
10,640
7,240
7,240
0
0
0
0007,2407,24010,64010,86140,25334,91135,62623,23214,12711,42911,24111,22310,87310,87910,87810,88427,39642,37455,15865,38572,99878,31082,34285,909118,563120,338123,547121,117274,142278,514196,480169,274000112,744000
       Other Liabilities 
0
0
0
348
0
0
0
180
0
0
117,390
120,977
123,463
120,285
118,536
85,901
72,908
68,876
72,998
65,385
55,158
42,374
27,396
10,884
10,878
10,879
10,873
11,223
11,241
11,429
14,127
23,232
26,527
26,734
33,019
10,861
10,640
7,240
7,240
0
0
0
0007,2407,24010,64010,86133,01926,73426,52723,23214,12711,42911,24111,22310,87310,87910,87810,88427,39642,37455,15865,38572,99868,87672,90885,901118,536120,285123,463120,977117,39000180000348000
> Total Stockholder Equity
0
0
0
-87,162
0
0
0
-113,691
-121,641
-125,473
-130,473
116,899
111,601
104,109
94,579
84,185
70,806
55,337
32,139
8,984
31,681
12,563
-2,732
66,905
62,202
84,140
75,325
72,547
120,044
110,564
102,933
75,997
112,437
84,089
65,156
8,281
-14,776
325
-869
-1,428
-2,336
5,170
5,170-2,336-1,428-869325-14,7768,28165,15684,089112,43775,997102,933110,564120,04472,54775,32584,14062,20266,905-2,73212,56331,6818,98432,13955,33770,80684,18594,579104,109111,601116,899-130,473-125,473-121,641-113,691000-87,162000
   Common Stock
0
0
0
723
0
0
0
0
0
1
0
15
15
15
15
15
15
15
15
15
19
19
19
24
24
24
24
25
35
35
36
36
36
36
37
37
37
37
37
37
37
37
373737373737373736363636353525242424241919191515151515151515150100000723000
   Retained Earnings Total Equity000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
-430
-381
-395
-230
-138
-90
-161
-48
-47
-114
-105
-181
469
226
120
43
-55
-37
46
74
31
39
70
42
18
9
3
1
-2
-2
-2
-2
0
0
0
000-2-2-2-213918427039317446-37-5543120226469-181-105-114-47-48-161-90-138-230-395-381-4300000000
   Capital Surplus 000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
7,200
9,347
35,445
34,343
285,771
287,596
289,423
292,486
296,035
298,304
301,741
304,830
306,828
351,504
354,584
357,748
441,795
444,940
449,483
452,670
461,425
518,494
521,503
523,715
526,244
531,240
534,854
540,560
551,959
555,576
555,304
555,802
556,672
557,156
557,453
557,453557,156556,672555,802555,304555,576551,959540,560534,854531,240526,244523,715521,503518,494461,425452,670449,483444,940441,795357,748354,584351,504306,828304,830301,741298,304296,035292,486289,423287,596285,77134,34335,4459,3477,2000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2013-12-31)

Gross Profit (+$)
totalRevenue1,369
Cost of Revenue-12
Gross Profit1,3571,357
 
Operating Income (+$)
Gross Profit1,357
Operating Expense-39,386
Operating Income-15,046-38,029
 
Operating Expense (+$)
Research Development11,857
Selling General Administrative27,529
Selling And Marketing Expenses0
Operating Expense39,38639,386
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,565
Other Finance Cost-1,565
Net Interest Income0
 
Pretax Income (+$)
Operating Income-15,046
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-16,582-38,025
EBIT - interestExpense = -39,561
-16,582
-12,859
Interest Expense1,565
Earnings Before Interest and Taxes (EBIT)-37,996-15,017
Earnings Before Interest and Taxes (EBITDA)-37,274
 
After tax Income (+$)
Income Before Tax-16,582
Tax Provision-0
Net Income From Continuing Ops-14,424-16,582
Net Income-14,424
Net Income Applicable To Common Shares-14,424
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring20,480
Other Operating Expenses39,386
Total Other Income/Expenses Net22,9790
 

Technical Analysis of Affymax
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Affymax. The general trend of Affymax is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Affymax's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Affymax Inc..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0008 < 0.0008 < 0.0008.

The bearish price targets are: 0.0008 > 0.0008 > 0.0007.

Tweet this
Affymax Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Affymax Inc.. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Affymax Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Affymax Inc.. The current macd is 0.00000.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Affymax price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Affymax. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Affymax price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Affymax Inc. Daily Moving Average Convergence/Divergence (MACD) ChartAffymax Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Affymax Inc.. The current adx is 68.10.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Affymax shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Affymax Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Affymax Inc.. The current sar is 0.03406654.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Affymax Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Affymax Inc.. The current rsi is 51.21. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Affymax Inc. Daily Relative Strength Index (RSI) ChartAffymax Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Affymax Inc.. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Affymax price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Affymax Inc. Daily Stochastic Oscillator ChartAffymax Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Affymax Inc.. The current cci is -33.13452618.

Affymax Inc. Daily Commodity Channel Index (CCI) ChartAffymax Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Affymax Inc.. The current cmo is 6.97322589.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Affymax Inc. Daily Chande Momentum Oscillator (CMO) ChartAffymax Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Affymax Inc.. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Affymax Inc. Daily Williams %R ChartAffymax Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Affymax Inc..

Affymax Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Affymax Inc.. The current atr is 0.00106028.

Affymax Inc. Daily Average True Range (ATR) ChartAffymax Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Affymax Inc.. The current obv is 50,031.

Affymax Inc. Daily On-Balance Volume (OBV) ChartAffymax Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Affymax Inc.. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Affymax Inc. Daily Money Flow Index (MFI) ChartAffymax Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Affymax Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Affymax Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Affymax Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.209
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Affymax with someone you think should read this too:
  • Are you bullish or bearish on Affymax? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Affymax? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Affymax Inc.

I send you an email if I find something interesting about Affymax Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Affymax Inc..

Receive notifications about Affymax Inc. in your mailbox!